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Abstract
A large proportion of age-related hearing loss is caused by loss or damage to outer hair cells in the organ of Corti. The organ
of Corti is the mechanosensory transducing apparatus in the inner ear and is composed of inner hair cells, outer hair cells,
and highly specialized supporting cells. The mechanisms that regulate differentiation of inner and outer hair cells are not
known. Here we report that fibroblast growth factor 20 (FGF20) is required for differentiation of cells in the lateral cochlear
compartment (outer hair and supporting cells) within the organ of Corti during a specific developmental time. In the
absence of FGF20, mice are deaf and lateral compartment cells remain undifferentiated, postmitotic, and unresponsive to
Notch-dependent lateral inhibition. These studies identify developmentally distinct medial (inner hair and supporting cells)
and lateral compartments in the developing organ of Corti. The viability and hearing loss in Fgf20 knockout mice suggest
that FGF20 may also be a deafness-associated gene in humans.
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Introduction
Congenital hearing loss is one of the most common hereditary
diseases, affecting 2–3 infants per 1,000 live births [1]. Acquired
age-related hearing loss affects one-third of people over the age of
65 [2]. A large proportion of age-related hearing loss is
sensorineural and is caused by loss or damage to outer hair cells
(OHC) in the organ of Corti (OC) [3,4]. The OC is the sensory
transducing apparatus in the cochlea and is composed of one row
of inner hair cells (IHC) and three rows of OHCs that are
separated by two pillar cells (PCs) that form the tunnel of Corti.
Each sensory hair cell is associated with an underlying supporting
cell (SC). Although there has been progress in understanding
mechanisms of hair cell (HC) and SC differentiation [5,6], the
cellular signals that specify the distinct phenotypes of cochlear
IHCs and OHCs are not known [7].
Fibroblast growth factor (FGF) signaling has essential functions
at several stages of inner ear development. In the embryonic day
9–10 (E9–E10) developing mouse, FGF3, FGF8, and FGF10 are
essential for development of the otic vesicle [8]. These ligands
signal through FGF receptor (FGFR) 2b in otic epithelium, and
mice lacking Fgfr2b show impaired otic vesicle development [9]. At
later stages of development, FGF signaling is required for
morphogenesis of the organ of Corti. At E11.5, Fgfr1 is expressed
in the ventromedial wall of the otocyst, the region that will give rise
to the cochlea [10]. At E15, Fgfr1 expression is observed in the
sensory epithelium of the developing cochlea [11,12]. Conditional
disruption of Fgfr1 in sensory epithelial progenitor cells (with
Foxg1
cre) resulted in a severe reduction in HC number, possibly due
to reduced proliferation of progenitor cells [10]. A similar
phenotype was also observed in organ cultures treated with FGFR
inhibitors [11]. Fgf20 is expressed in the presumptive epithelial
domain of the developing cochlea at E13.5 and antibody
inhibition of FGF20 in cochlear organ culture resulted in fewer
SCs and HCs [11]. These studies suggest that FGF20 might be the
ligand for FGFR1 during the early growth and differentiation
stages of cochlear development.
At later stages of organ of Corti development (after E15),
inhibition of FGF signaling results in loss of PCs, suggesting an
additional stage-specific role for FGF signaling [13]. Genetic and
gene expression data suggest that this function is mediated by FGF8
signaling to FGFR3. Fgfr3 is expressed after E15.5 in undifferen-
tiated postmitotic progenitor cells that are thought to have the
capacity to form OHCs, Deiters’ cells (DCs), PCs, and Hensen’s
cells (HeCs) [12–15]. Genetic disruption of Fgfr3 prevents the
differentiation of PCs and the formation of the tunnel of Corti and
results in deafness [13,15,16]. FGF8 is expressed in IHCs where it
induces differentiation of PCs and formation of one row of OHCs
through signaling to FGFR3 [10,17,18].
The mechanisms that regulate the formation of OHCs are
particularly significant, given the importance of OHCs for hearing
function and age-related hearing loss. Although mouse mutants
lacking FGFR1 suggest a role for FGF signaling in OHC
development [10], the underlying mechanisms regulating OHC
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FGF20 (Fgf20
bGal/bGal). We show that Fgf20
bGal/bGal mice are
viable, healthy, and congenitally deaf, specifically lack OHCs and
outer supporting cells, and have patterning defects throughout
most of the cochlear sensory epithelium. These studies show that
the organ of Corti can be subdivided into developmentally distinct
medial (IHCs and inner SCs) and lateral (OHCs and outer SCs)
compartments that are under the control of distinct developmental
programs. This model posits the existence of distinct progenitor
cells that give rise to medial and lateral compartments of the OC.
Results
Loss of Fgf20 Results in Congenital Hearing Loss and
Disorganization of the Organ of Corti
To study the function of Fgf20 in vivo, we generated Fgf20 null
mice in which exon 1 was replaced with a b-galactosidase gene
(Fgf20
bGal) (Figure S1). Homozygous Fgf20
bGal/bGal mice were
viable, fertile, and healthy. However, Fgf20
bGal/bGal mice lacked
auditory perception (no ear twitch response to loud noise) and had
auditory brainstem response (ABR) thresholds greater than 40 db
above controls in the 5–20 kHz range (Figure 1A). Histological
sections of the adult inner ear of Fgf20
bGal/bGal mice showed
normal gross morphology of the temporal bone and cochlea
(Figure S1E–G); however, the OC showed significant dysmor-
phology, with variability in the degree of disorganization along the
length of the cochlea (Figure 1B). Some sections showed almost
complete absence of sensory HCs and SCs, while other sections
showed loss of OHCs and DCs. In contrast, wild type and
heterozygous littermates showed normal cochlear organization,
with one IHC, three OHCs, one inner and outer pillar cell (IPC,
OPC), and three DCs (Figure 1B).
Fgf20 Is Expressed in the Inner Ear Prosensory Epithelium
and in Differentiated Supporting Cells
To identify spatial and temporal patterns of Fgf20 expression in
the developing inner ear, we stained whole mount preparations for
b-galactosidase (bGal) activity. In Fgf20
bGal/+ embryos, bGal was
first detected in the anterio-ventral region of the otic vesicle at
E10.5, the region of the otic vesicle where sensory progenitor cells
are located (Figure 2A) [19]. In histological sections of the otic
vesicle, Fgf20-bGal was expressed within the domain of Sox2+
sensory progenitor cells at E11.5 (Figure 2B). At E14.5, the time of
sensory cell specification, Fgf20-bGal was expressed in the Sox2+,
p27+ sensory domain (Figure 2C,D), in an apical to basal graded
expression pattern, similar to previously reported expression
patterns for Fgf20 [11]. At postnatal day 0 (P0), a time when
almost all sensory cells have completed differentiation, Fgf20-bGal
was expressed throughout all inner ear sensory epithelia (Figure 2E
and Figure S2). In the cochlea, Fgf20-bGal expression was
restricted to SCs and was expressed in a graded medial to lateral
pattern, with highest levels in the inner phalangeal cells (IPhC) and
lower levels in PCs (Figure 2F and Figure S2A). Fgf20-bGal was
also expressed in the vestibular sensory organs of the inner ear,
including the maculae of the utricle and saccule and cristae of the
semicircular canals (Figure S2B–F). Fgf20
bGal/bGal mice did not
show any vestibular dysfunction (unpublished data).
FGF20 Is Required for Patterning Cochlear Sensory Cells
and Formation of the Lateral Compartment
To further analyze the hair cell phenotype in the cochlea, we
isolated whole cochleae at P0 and stained with phalloidin, as well
as with antibodies against Myo6 and Calretinin (Figure 3 and
Figure S3) [20,21]. Wild type cochleae showed three rows of
OHCs and one row of IHCs throughout the OC (Figure 3A).
However, in the cochlea of Fgf20
bGal/bGal newborn pups, the
proximal base region contained only two rows of OHCs and one
row of IHCs. In the middle and apical regions, patches of HCs
were observed (Figure 3B). Such patches typically contained three
rows of OHCs and two rows of IHCs, and there were no HCs in
the regions between the patches. Finally, no distinct phalloidin or
Myo6 positive HCs were present in the most apical region.
Because HC differentiation progresses from the base to the apex of
the cochlea, we sought to determine whether differentiation of
HCs in the distal apex region of Fgf20
bGal/bGal cochlea was delayed
or whether HCs were lost. At P7, expression of HC markers in the
distal apex of Fgf20
bGal/bGal and Fgf20
bGal/+ cochlea were
comparable (Figure 3 and Figure S3), indicating that HCs were
not lost but rather delayed in differentiation. Consistent with
delayed HC differentiation, at E16.5, HCs were undifferentiated
in the middle region of the cochlea of Fgf20
bGal/bGal compared to
Fgf20
bGal/+ cochlea (Figure S3A,B).
To identify whether SCs were properly formed, we stained P0
cochlea with antibodies against Prox1 and p75. At P0, Prox1 is
expressed at high levels in DCs and PCs, while p75 labels PCs and
HeCs [22,23]. In Fgf20
bGal/+ cochleae, there were two rows of
PCs, three rows of DCs, and one row of HeCs (Figure S3G).
Immunolabeling of Fgf20
bGal/bGal cochleae showed that all the SC
types existed, although with dysmorphology. Similar to HC
patterns, two rows of DCs and two rows of PCs were formed at the
base region of Fgf20
bGal/bGal cochlea (Figure S3H). In the middle
region, where HCs were clustered in patches, SCs were formed in
accordance with the hair cell pattern (three rows of DCs and two
rows of PCs). No SCs were observed in the space between the
sensory patches. Interestingly, within a patch, OHCs were
surrounded by PCs and HeCs, as indicated by continuous p75
staining (Figure S3J). Unlike HCs, apical SCs were differentiated,
as indicated by Prox1 staining (Figure S3G,H), suggesting that
apical SCs may develop normally in the absence of FGF20.
Because of the delay in HC differentiation and patch formation,
the total numbers of cochlear HCs were quantified at P4, a time
Author Summary
A large proportion of age-related hearing loss is caused by
loss or damage to outer hair cells in the organ of Corti. The
organ of Corti is a highly specialized structure in the inner
ear that is composed of inner hair cells, outer hair cells, and
associated supporting cells. Although we understand
some of the mechanisms that regulate hair cell versus
supporting cell differentiation, the mechanisms that
regulate differentiation of inner versus outer hair cells
are not known. One potential candidate is fibroblast
growth factor (FGF) signaling, which is known to regulate
the morphogenesis of many sensory organs, including the
organ of Corti. In this study, we find that FGF20 signaling is
required at a specific time during development to initiate
differentiation of cells in the mouse lateral cochlear
compartment (which contains outer hair cells and
supporting cells, but not inner hair cells). In the absence
of FGF20, mice are deaf, and lateral compartment cells
remain undifferentiated and unresponsive to mechanisms
that regulate the final stages of differentiation. These
findings are significant given the importance of outer hair
cells during age-related hearing loss. Our studies also
suggest that genetic mutations in FGF20 may result in
deafness in humans and that FGF20 may be an important
factor for the repair or regeneration of sensory cells in the
inner ear.
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bGal/+ and Fgf20
bGal/bGal cochlea appeared fully
differentiated (Figure S3K). Surprisingly, although there were two
rows of IHCs in patches and no IHCs in the region between
patches, the total number of IHCs was the same in Fgf20
bGal/+ and
Fgf20
bGal/bGal cochlea (680618, n=4inFgf20
bGal/+ and 685658,
n=3 in Fgf20
bGal/bGal, p=0.4). However, the number of OHCs
was decreased by 70% in Fgf20
bGal/bGal compared to Fgf20
bGal/+
cochlea (2035642 in Fgf20
bGal/+ and 601660 in Fgf20
bGal/bGal,
p,0.001) (Figure 3D). In addition, cochlear length was decreased
by 10% in Fgf20
bGal/bGal compared to Fgf20
bGal/+ mice (Figure 3E).
We also counted the number of SCs (DCs, OPCs, and IPCs)
normalized to 100 mm intervals. Similar to the large decrease in
the number of OHCs, the number of DCs+OPCs was decreased
by 52% in Fgf20
bGal/bGal compared to Fgf20
bGal/+ cochlea (5563,
n=6inFgf20
bGal/+ and 2664, n=8inFgf20
bGal/bGal per 100 mm,
p,0.001) (Figure 3F). In contrast, the number of IPCs was
decreased by only 15% in Fgf20
bGal/bGal compared to Fgf20
bGal/+
cochlea (1961i nFgf20
bGal/+ and 1661i nFgf20
bGal/bGal per
100 mm, p,0.01) (Figure 3F). Next, we compared the ratio of
different cell types in Fgf20
bGal/bGal and Fgf20
bGal/+ cochlea. In
Fgf20
bGal/+ cochlea, the ratio of OHC/IHC was 3.460.3.
However, in Fgf20
bGal/bGal cochlea this ratio was decreased (by
62%) to 1.360.6 (p,0.001). Additionally, the ratio of DC+OPC/
IPC in Fgf20
bGal/+ cochlea was 2.960.1, but was decreased (by
45%) to 1.660.2 in Fgf20
bGal/bGal cochlea (p,0.001). Interestingly,
within the lateral and medial compartments, the ratio of
DC+OPC/OHC (1.460.0 in Fgf20
bGal/+ and 1.560.1 in
Fgf20
bGal/bGal, p,0.01) and IPC/IHC (1.660.1 in Fgf20
bGal/+
and 1.260.1 in Fgf20
bGal/bGal, p,0.001) was slightly increased (by
7%) or decreased (by 25%), respectively, in Fgf20
bGal/bGal
compared to Fgf20
bGal/+ cochlea. These ratios indicate that
absence of FGF20 primarily affects lateral compartment cells
(i.e., OHCs and DCs).
Exogenous FGF Rescues Loss of Sensory Cell Before E14.5
Next we asked whether loss of the lateral compartment was due
to loss of sensory domain progenitor cells. To do this, we labeled
E13.5 or E14.5 cochlea for Sox2, a marker for sensory progenitors,
or Jag1, a marker for Ko ¨lliker’s organ [24,25]. The expression
pattern of Sox2 and Jag1 was comparable in Fgf20
bGal/bGal and
Fgf20
bGal/+ cochlea at E13.5 and E14.5 (Figure S4A–F). Addi-
tionally, cell proliferation was comparable in Fgf20
bGal/bGal and
Fgf20
bGal/+ E13.5 cochlea (Figure S4G,H), indicating that the
sensory domain had formed normally. Next, we hypothesized that
FGF20 may play a role in lateral compartment differentiation. To
test this, we isolated E13.5 or E14.5 cochlea and treated explants
with 1 mM FGF9 (which shows similar biochemical activity in vitro
compared to FGF20) [26] beginning at E13.5, E14.5, E15.5, and
E16.5. Control cultures were maintained in parallel, but did not
receive FGF9. Cochlear explants were cultured in these media for
5 d and then stained with Myo7a antibodies (to identify HCs)
[20,27]. Untreated Fgf20
bGal/+ explants showed normal patterning,
with one row of IHCs and 3–4 rows of OHCs (Figure 4A,E and
Figure S5A,E). Also, untreated Fgf20
bGal/bGal explants showed the
expected patterning defects (patches of HCs and SCs towards the
apical cochlea) and loss of HCs (Figure 4C,G and Figure S5C,G).
Notably, however, treatment of Fgf20
bGal/bGal explants with FGF9
at E13.5 and E14.5 resulted in rescue of the cochlear phenotype,
with the cochlea showing a normal and contiguous pattern of
sensory cells and increased numbers of OHCs (162653, n=2
without FGF9 and 4866122, n=3 with FGF9 treatment at E13.5,
p,0.05, and 376696, n=3 without FGF9 and 7256100, n=3
with FGF9 treatment at E14.5, p,0.01) compared to untreated
explants (Figure 4C,D,I and Figure S5C,D,I). Finally, treatment of
Fgf20
bGal/bGal explants with FGF9 at E15.5 or E16.5 did not affect
the number of HCs (16860, n=2 without FGF9 and 176690,
n=3 with FGF9 treatment at E15.5, p=0.9, and 238640, n=4
Figure 1. Congenital hearing loss and cochlear dysgenesis caused by loss of Fgf20 in the developing cochlear sensory epithelium.
(A) Auditory brainstem response test of 6-wk-old mice showing normal and comparable thresholds in wild type (n=3) and Fgf20
bGal/+ (n=5) mice and
a lack of response in Fgf20
bGal/bGal mice (n=5) in the 5–40 kHz range. (B) Histology of the inner ear showing normal organ of Corti structure in wild
type and Fgf20
bGal/+ cochlea in which there are three outer hair cells (OHC), one inner hair cell (IHC), three Deiters’ cells (DC), two pillar cells (PC), and
several inner phalangeal cells (IPhC). Fgf20
bGal/bGal cochlea showed disorganization and loss of sensory cells in the organ of Corti. Scale bar: 100 mm.
doi:10.1371/journal.pbio.1001231.g001
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p=0.3) (Figure 4G,H,I and Figure S5G,H,I), indicating that
normal differentiation of lateral compartment cells requires active
FGF signaling prior to E14.5. Patterning and numbers of SCs
were also rescued by FGF9 treatment (640649, n=3 without
FGF9 and 1001639, n=4 with FGF9 treatment at E14.5,
p,0.001) (Figure 4J–N). BrdU labeling of these cultures indicated
that treatment of Fgf20
bGal/bGal cochlea with FGF9 did not induce
renewed proliferation within the sensory epithelia (Figure S5J and
K) at this stage, which indicated that FGF9 treatment functioned
to induce lateral compartment cell differentiation into HCs and
SCs. Also, treatment of Fgf20
bGal/+ explants with FGF9 did not
change the morphology or number of HCs or SCs, indicating that
FGF signaling is not sufficient to induce ectopic HC or SC
formation (Figure 4B,F,I,K and Figure S5B,F,I). Similar experi-
ments were repeated with recombinant FGF20 protein with
qualitatively similar results, although FGF20 was less active than
FGF9 in this assay (unpublished data).
Figure 2. Expression of Fgf20 in the developing inner ear. (A) bGal staining of E10.5 embryos showing anterio-ventral expression of Fgf20 in
the otic vesicle (OV). (B,C) Co-labeling of bGal and Sox2 showing that at E11.5 (B), the Fgf20 expression domain is within the Sox2 expressing sensory
patch and at E14.5 (C), Fgf20 expression overlaps with the Sox2 expressing sensory domain. (D) Staining for bGal and for p27 expression showing that
at E14.5, Fgf20 expression partially overlaps with the medial region of p27 expression in the cochlear sensory epithelium. (E) bGal staining at P0
showing Fgf20
bGal expression in all sensory domains of the inner ear, including the cochlea (co), utricle (ut), saccule (sac), and crista of the semicircular
canals (pc, lc, ac). (F) Co-staining of bGal, phalloidin, and p75 (pillar cells, PC) in P0 cochlea showing low-level Fgf20 expression in medial supporting
cells (Deiters’ cells, DC) and HeC (lower panels), moderate expression in PCs, and highest expression in the inner phallangial cells (IPhC). Fgf20
bGal
appears to be excluded from hair cells (upper panels). Scale bar: 100 mm. D, dorsal; A, anterior; M, medial.
doi:10.1371/journal.pbio.1001231.g002
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PLoS Biology | www.plosbiology.org 4 January 2012 | Volume 10 | Issue 1 | e1001231Figure 3. Fgf20 is necessary for formation of the lateral compartment of the organ of Corti. Phalloidin staining of P0 and P7 cochleae
showing hair cells. In Fgf20
bGal/+ cochlea, (A) there is one row of inner hair cells (IHC) and three rows of outer hair cells (OHC) throughout the cochlea.
At P0, apical hair cells are not fully differentiated; by P7, apical differentiation is complete. In Fgf20
bGal/bGal cochlea (B), the cochlear base (base) has
one row of inner hair cells and two rows of outer hair cells. The mid-cochlea (middle) forms patches of hair cells with two rows of IHCs and three rows
of OHCs separated by gaps that lack hair cells. The apex (apex) contains hair cells that are much less differentiated and the distal apex (end of apex)
contains no identifiable hair cells. At P7, the hair cells in the distal apex of Fgf20
bGal/bGal and Fgf20
bGal/+ cochlea are comparable. (C) Diagram showing
the cochlear regions examined in (A, B); b, base; m, middle; a, apex, a9, end of apex. (D) Quantification of hair cell numbers at P4. Total numbers of
IHCs and OHCs were counted from Fgf20
bGal/+ (n=3) and Fgf20
bGal/bGal (n=3) cochlea. The numbers of IHCs were comparable, while the numbers of
OHCs were decreased by 70% in Fgf20
bGal/bGal compared to Fgf20
bGal/+ cochlea. Total numbers of hair cells were decreased by 50% in Fgf20
bGal/bGal
cochlea. (E) Length of cochlea at P4. Fgf20
bGal/bGal cochlea length (n=3) was decreased by 10% compared to Fgf20
bGal/+ (n=3). (F, G) Quantification of
supporting cell numbers at P0. (F) Number of supporting cells, identified by staining for Prox1 (Figure S3G,H), and hair cells, were counted from base,
middle, and apex regions of the OC and normalized to 100 mm from Fgf20
bGal/+ (n=6) and Fgf20
bGal/bGal (n=8) mice. IHC numbers were slightly
increased while OHC numbers were decreased by 57% in Fgf20
bGal/bGal compared to Fgf20
bGal/+ cochlea. Numbers of Deiters’ cells (DC) and outer
pillar cells (OPC) were decreased by 52%, whereas numbers of inner pillar cells (IPC) were only slightly decreased in Fgf20
bGal/bGal compared to
Fgf20
bGal/+ cochlea. (G) Ratio of hair cells and supporting cells in P0 cochlea. The ratio of outer compartment cells (OHC, OPC, DC) to inner
compartment cells (IHC, IPC) was decreased in Fgf20
bGal/bGal compared to Fgf20
bGal/+ cochlea. Small changes in the ratio of outer compartment
supporting cells (DC+OPC) to OHCs and inner compartment supporting cells (IPC) to IHCs were observed. * p,0.01.
doi:10.1371/journal.pbio.1001231.g003
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bGal/bGal Cochlea
Contains Undifferentiated Postmitotic Sensory Cells
To determine whether the missing outer compartment cells
were lost or were still present in an undifferentiated state, we
stained whole cochleae of P0 pups with E-Cadherin antibodies,
which marks lateral compartment cells at late gestational and
postnatal stages of development [6]. In Fgf20
bGal/+ cochlea, E-
Cadherin labeled all lateral compartment cells including OHCs,
DCs, and HeCs (Figure 5A, upper). Interestingly, in Fgf20
bGal/bGal
cochlea, E-Cadherin was highly expressed in the region between
the sensory patches where there were no HCs or SCs (Figure 5A,
lower), identifying these as potential lateral compartment cells. We
also labeled specimens for Sox2 and with phalloidin. At P0, Sox2
labels all supporting cells, but at earlier stages of sensory domain
formation (E14.5), Sox2 labels undifferentiated sensory cells [24].
We observed normal patterns of Sox2 expression in Fgf20
bGal/+
cochlea. However, in Fgf20
bGal/bGal cochlea, Sox2 was expressed
both in supporting cells and in the regions between the sensory
patches (Figure 5B arrows). We also examined the expression of
p27, a marker of SCs and undifferentiated sensory progenitors
[28]. The expression pattern of p27 was similar to that of Sox2,
with high expression in cells in the region between the sensory
patches (Figure 5C). Although the identity of the cells within these
gaps in the sensory epithelium is not known, these expression
studies suggest that these cells may be an arrested progenitor-like
cell or a differentiated non-sensory cell. To determine whether the
lineage precursors of these cells could be rescued, E14.5 Fgf20
bGal/
bGal cochlea explants were treated with or without FGF9 and co-
stained for Sox2 and Prox1 expression after 5 d in culture. In
explants not exposed to FGF9, the region between the patches was
Figure 4. FGF20 initiates lateral compartment differentiation before E14.5. (A–H) Immunostaining of Myo7a in Fgf20
bGal/+ and Fgf20
bGal/bGal
cochlear explants treated with or without FGF9 and cultured for 5 d (schematic). Treatment of Fgf20
bGal/+ explants with FGF9, either at E14.5 (B) or
E15.5 (F), did not have any effect on hair cell number compared to untreated explants (A,E). Treatment of Fgf20
bGal/bGal explants with FGF9 at E14.5
resulted in increased numbers of hair cells and decreased gaps (arrows) between hair cell clusters (D) compared to untreated explants (C). Treatment
of Fgf20
bGal/+ or Fgf20
bGal/bGal explants with FGF9 at E15.5 did not affect hair cell number or the formation of gaps (arrows) lacking sensory cells (G, H).
(I) Quantitation of the number of hair cells. The number of OHCs and total hair cells were rescued by treatment with FGF9 at E14.5 but not at E15.5.
* p,0.05. (J–M) Immunostaining for Prox1 in Fgf20
bGal/+ and Fgf20
bGal/bGal explants treated with or without FGF9 at E14.5 and cultured for 5 d
(schematic). Treatment of Fgf20
bGal/+ explants with FGF9 did not affect supporting cell number (K) compared to untreated explants (J). Treatment of
Fgf20
bGal/bGal explants with FGF9 at E14.5 resulted in increased numbers of supporting cells and decreased gaps between sensory cell clusters (M)
compared to untreated explants (L). (N) Quantitation of numbers of supporting cells in explants. The number of supporting cells was partially rescued
in Fgf20
bGal/bGal explants by treatment with FGF9 at E14.5.
doi:10.1371/journal.pbio.1001231.g004
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FGF9, these cells became Sox2+; Prox1+ (Figure 5D, right),
indicating that the lineage precursors of these cells are undiffer-
entiated sensory cells and that exposure to FGF9 induced their
differentiation into lateral HCs and SCs, such as OHCs and DCs.
This finding indicates that FGF signaling is required to induce
differentiation of cells in the lateral cochlear compartment.
Undifferentiated Sensory Cells Are Not Influenced by
Notch Mediated Lateral Inhibition
Next, we asked whether FGF20 functions to induce differen-
tiation of a specific cell phenotype in the lateral compartment
versus functioning as a gate to permit lateral compartment
differentiation. To answer this question, we treated E14.5 cochlea
explants with DAPT, a c-secretase inhibitor, which inhibits the
Notch signaling pathway [29]. At this stage of development, the
Notch pathway functions to prevent SC differentiation into HCs
[30]. In Fgf20
bGal/+ explants treated with DAPT, the domain of
IHCs and OHCs expanded at the expense of SCs, compared to
untreated explants (Figure 6A and B). In Fgf20
bGal/bGal explants,
treatment with DAPT also expanded the IHC domain, similar to
heterozygous explants treated with DAPT. However, the domain
of OHCs in DAPT-treated Fgf20
bGal/bGal explants was still smaller
than the OHC domain of DAPT-treated Fgf20
bGal/+ explants and
also contained patches of undifferentiated sensory progenitor cells
(Figure 6C and D). This finding indicates that DAPT treatment
did not induce differentiation of otherwise FGF20-dependent
precursor cells. Also, we observed a dramatic reduction of SCs
following DAPT treatment of either genotype, indicating that all
SCs were converted into HCs (Figure 6F and H). Together, these
data support a model in which FGF20 functions as a permissive
factor that is required to initiate lateral compartment differenti-
ation before E14.5 (Figure 7). Without FGF20, lateral sensory cells
remained in an undifferentiated state.
Discussion
The mechanisms that differentially regulate formation of inner
versus outer hair cells are poorly understood. In this study, we
show that Fgf20
bGal/bGal mice have a specific deficiency in the
formation of OHCs and outer supporting cells that make up the
lateral compartment of the organ of Corti. These observations
suggest that FGF signaling may regulate the growth or
differentiation capacity of a progenitor cell that gives rise to
lateral compartment cells and that medial (IHCs and inner SCs)
and lateral compartment development may be controlled by
distinct mechanisms (Figure 7). Additionally, since Fgf20
bGal/bGal
mice are viable and healthy, but are congenitally deaf, FGF20 is
likely a candidate gene for hereditary deafness in humans.
Figure 5. Lack of FGF20 results in undifferentiated lateral compartment cells. (A) Co-immunostaining of E-Cadherin and Myo6 showing
that E-Cadherin stains lateral compartment cells in Fgf20
bGal/+ cochlea (A, upper). In Fgf20
bGal/bGal cochlea, E-Cadherin stains all lateral compartment
cells including cells localized in the region between sensory patches (A, lower, arrow). (B) Co-immunostaining of Sox2 and phalloidin showing that
Sox2 labels supporting cells in Fgf20
bGal/+ cochlea (B, upper). In Fgf20
bGal/bGal cochlea, the region between patches was marked by strong Sox2
staining (B, lower, arrows). (C) Co-immunostaining of p27 and phalloidin showing that p27 stains supporting cells in Fgf20
bGal/+cochlea (C, upper). In
Fgf20
bGal/bGal cochlea, the region between patches was marked by strong p27 staining (C, lower, arrows). (D) Co-immunostaining of Sox2 and Prox1 of
Fgf20
bGal/bGal explants treated with or without FGF9. Without FGF9 treatment (left), Sox2+/Prox12 cells were localized in the region between sensory
patches (arrows). Treatment of Fgf20
bGal/bGal explants with FGF9 induced Sox2+/Prox12 cells to express Prox1 (right).
doi:10.1371/journal.pbio.1001231.g005
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8p22–21.3 within the autosomal recessive non-syndromic hearing
impairment locus, DFNB71 [31].
Timing of FGF Signaling and Sensory Cell Differentiation
To identify the developmental time when FGF20 functions to
regulate lateral compartment differentiation, rescue experiments
were performed in which Fgf20
bGal/bGal cochlea were placed in
culture prior to differentiation (E13.5) and then FGF9 was added
to the culture at different time points. These experiments showed
that the lateral compartment differentiation defects in Fgf20
bGal/bGal
mice could only be rescued if FGF9 was added at or before E14.5.
However, treatment with FGF9 at or after E15.5 failed to
rescue the phenotype of Fgf20
bGal/bGal m i c e .T h i si si n t e r e s t i n g
Figure 6. Notch signaling does not influence undifferentiated lateral compartment cells. (A–D) Immunostaining of Myo7a in Fgf20
bGal/+
and Fgf20
bGal/bGal explants treated with or without DAPT at E14 and cultured for 5 d (schematic). Treatment of Fgf20
bGal/+ explants with DAPT resulted
in increased numbers of inner and outer hair cells (B) compared to untreated explants (A). Fgf20
bGal/bGal explants treated with DAPT showed a
comparable increase of IHCs (C) but a decreased expansion of the OHC compartment (D), compared to Fgf20
bGal/+ explants treated with DAPT (A, B).
Lower panels in (A–D) show OHCs false-colored in yellow. (E–H) Staining for Prox1 expression shows absence of Prox1 expressing cells in explants
treated with DAPT indicating that inhibition of Notch signaling blocks formation of supporting cells in both Fgf20
bGal/+ and Fgf20
bGal/bGal explants.
Lower panels show enlarged region (box) with only background Prox1 staining in DAPT treated explants.
doi:10.1371/journal.pbio.1001231.g006
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specification is completed and HC and SC differentiation
begins [5,32].
The changes in the cochlear epithelium that renders it non-
responsive to FGF signaling after E14.5 are not known.
Possibilities include loss of FGFR1 expression, uncoupling of
FGFR1 to cellular signal transduction pathways, or loss of
cofactors required for ligand activation of FGFR1. In lung
development, a feed forward signaling loop couples FGF9 with
Wnt/b-catenin signaling and maintenance of FGFR expression.
Loss of Fgf9 resulted in loss of Fgfr1 and Fgfr2 expression and
subsequent loss of responsiveness of explanted lung to exogenous
FGF9 [33]. If a similar feed forward loop functions in the inner ear
prosensory epithelium, loss of FGFR expression in Fgf20
bGal/bGal
mice could explain the loss of responsiveness to exogenous FGF
after E14.5. However, in the inner ear, FGF20 continues to be
expressed in IPhCs and at low levels in PCs until early postnatal
ages (Figure 2). This suggests that FGF20 signaling may have
additional roles in cochlear development. At P0, bGal staining
indicates that Fgf20 is expressed at highest levels in the cochlear
apex (Figure 2). Since differentiation of the apical cochlea is
delayed in Fgf20
bGal/bGal mice (Figure 3), FGF20 may function at
later stages of development to promote sensory cell maturation.
Because damage or loss of OHCs is thought to be a major cause
of sensorineural hearing loss, efforts to restore hearing in some
patients with sensorineural hearing loss will require regeneration of
OHCs. Understanding the changes that occur in sensory
progenitor cells between E14.5 and E15.5 is important because
they may provide clues about pathways required for reactivation
of OHC progenitors in the adult or protecting OHCs from
ototoxic damage. Although FGF20 signaling alone may not be
sufficient to induce regeneration of OHCs, it may be required in
combination with other signaling molecules. For example, in lung
development, responsiveness of lung tissue lacking FGF9 can be
restored by simultaneously treating Fgf9
2/2 explants with
activators of Wnt/b-catenin signaling and with FGF9 [34].
The FGF9 Family Has Unique Signaling Properties in
Development
The Fgf9 subfamily includes Fgf16 and Fgf20 [35]. Consistent
with the conserved sequences within this subfamily, the biochem-
ical activities of FGF20 are similar to that of FGF9 and FGF16
[26]. In vitro, FGF20 binds and activates c splice variants of
FGFR1, FGFR2, and FGFR3, which are generally expressed in
mesenchymal cells, and b splice variants of FGFR3, which are
expressed in epithelial cells [26]. However, the phenotype of
Fgf20
bGal/bGal mice is most similar to that of Fgfr1 conditional
deletion mutants, in which epithelial Fgfr1 was inactivated in the
developing inner ear sensory epithelium with Foxg1
cre [10]. The
phenotypic similarities strongly suggest that FGFR1 is the
physiological receptor for FGF20. Because, in vitro, FGF20
activates FGFR1c to a much greater extent than FGFR1b [26],
the FGFR1c variant may be expressed in the developing cochlear
sensory epithelium. Alternatively, unique cofactors within the
cochlear sensory epithelium may allow FGF20 to activate
FGFR1c.
FGF Signaling and Hair Cell Regeneration
The sensory epithelium of the mammalian cochlea cannot
regenerate following ototoxic or noise damage; however, the avian
and amphibian inner ear responds to ototoxic or noise-induced
injury with a robust regenerative response that results in complete
functional recovery [36]. The underlying mechanisms accounting
for this difference in regenerative capacity are not understood.
However, in principal, therapeutic reactivation of appropriate
signaling pathways in the mammalian inner ear should be able to
recapitulate the avian response, resulting in both functional repair
and prevention of further pathology. Our observation that FGF20
functions as a permissive factor for lateral compartment
differentiation suggests that FGF signaling may be a necessary
factor for promoting inner ear regeneration. Additionally,
zebrafish lacking FGF20 are viable and healthy, but have defects
in their ability to regenerate damaged fins [37]. These observa-
tions suggest that FGF signaling, and specifically FGF20 or related
FGFs, may be important factors for regeneration of a variety of
tissues, including the inner ear. Inducible genetic systems in the
mouse and the identification of signaling pathways that interact
with FGF20 will be required to test the protective or regenerative
potential of FGF20 in noise or ototoxic damaged mammalian
inner ear.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Washington University Division of
Comparative Medicine Animal Studies Committee (Protocol
Number 20100223). All efforts were made to minimize animal
suffering.
Generation of Fgf20 Mutant Mice
The Fgf20 targeting construct was made using recombineering
methods as previously reported [38]. Briefly, exon1 of Fgf20 was
replaced with a bGal–LoxP-neomycin-LoxP cassette to generate
Fgf20
bGal(neo)/+ mice. The neomycin gene was eliminated by mating
with b-actin
cre mice to generate Fgf20
bGal/+ mice. Fgf20
bGal/+ males
and females were crossed to generate Fgf20
bGal/bGal mice. Genotyp-
ing was performed using PCR1: CTGCATTC GCCTCGCC-
ACCCTTGCTACACT; PCR2: GGATCTGCAGGTGGAAGC-
CGGTGCGGCAGT; PCR3: GGCCTTCCTGTAGCCAGCTT-
TCATCAACAT primers, which amplify wild type (335 bp) and
mutant (498 bp) PCR fragments as indicated in Figure S1A. Mice
were maintained on a 129X1/SvJ;C57B6/J mixed background.
Fgf20
bGal/+ and Fgf20
bGal/bGal mice were viable and fertile.
Figure 7. Schematic model of sensory cell development in the
organ of Corti. Diagram showing that FGF20 specifically functions to
initiate lateral compartment development. The differential activity of
FGF20 suggests that there may be separate progenitor cells for the
medial and lateral cochlear compartments.
doi:10.1371/journal.pbio.1001231.g007
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Mice were anesthetized by i.p. administration of ketamine
(80 mg/kg) and xylazine (15 mg/kg), and maintained at 37uC
throughout the testing. ABR testing was carried out in a single
walled sound-attenuating room. Testing was similar to what has
been previously described [39]. Briefly, stimulus presentation and
data acquisition were performed with TDT System 3 equipment
using SigGen and BioSig software (Tucker Davis Technologies).
An ES-1 electrostatic speaker was placed 7 cm from the animal’s
right ear. Toneburst stimuli (5, 10, 20, 28, and 40 kHz) were 5 ms
in length with a 1-ms rise/fall time. Stimuli were presented at
decreasing intensities in 5 dB steps until Wave I was no longer
observed. Auditory profiles were recorded using platinum
subdermal needle electrodes (Grass Technologies) placed with
the recording electrode behind the right pinna, the reference
electrode at the vertex, and ground electrode in the skin of the
back. Responses were amplified and filtered (X 100,000 and low
filter: 100 Hz, high filter: 3,000 Hz) using a Grass P 55 preamp.
Tonebursts at each frequency and intensity were presented 1,000
times. Stimulus levels were calibrated using SigCal (Tucker Davis
Technologies) program with an ACO Pacific J inch microphone
placed where the mouse’s ear would be located.
RNA Extraction, cDNA Synthesis, and Quantitative RT-PCR
For detection of Fgf20 mRNA, E14.5 embryos were dissected
and inner ear tissue was isolated. RNA was extracted with the
RNeasy kit (Qiagen). cDNA synthesis used the SuperScript III
First-Strand Synthesis System for reverse transcription–polymer-
ase chain reaction (Invitrogen), following the manufacturer’s
protocol. Mouse Fgf20 mRNA levels were quantified using a
TaqMan gene expression assay (ABI Mm00748347_m1). TaqMan
assays were run in an ABI7500 fast real-time PCR machine.
bGal Staining
Cochleae were dissected from P0 pups in PBS and fixed
overnight in Mirsky’s Fixative (National Diagnostics). For whole
mount staining, samples were washed three times in PBT (PBS,
0.1% Tween-20) and incubated in bGal staining solution (2 mM
MgCl2, 35 mM potassium ferrocyanide, 35 mM potassium
ferricyanide, 1 mg/mg X-Gal in PBT) at 37uC until color reaction
was apparent. Samples were washed in PBS fixed in 10% formalin
and imaged under a dissecting microscope. For staining
histological sections, samples were cryosectioned, washed with
PBS, and incubated in bGal staining solution. Samples were
washed in PBS, embedded, and photographed.
Histology
For adult histology, mice were sacrificed with an overdose of
pentobarbital (200 mg/kg). Temporal bones were dissected free
from the skull and broken in half to expose the cochlea, which was
perfused via the round window with a solution containing 4%
paraformaldehyde and 0.1% glutaraldehyde. Cochleae were
further fixed in this solution overnight and then rinsed free of
aldehyde with several changes of PBS. They were then post-fixed
in 1% osmium tetroxide (30 min) and rinsed and dehydrated
through a series of acetones. Tissues were then infiltrated and
embedded in an epon-araldite mixture and polymerized overnight
at 60uC. Ten adjacent, 4 mm thick sections were saved from the
midmodiolar plane from each cochlea, counterstained with
toluidine blue, and coverslipped.
For frozen sections, embryos were fixed with 4% paraformal-
dehyde overnight and washed with PBS. Samples were soaked in
30% sucrose and embedded in OCT compound (Tissue-Tek).
Samples were sectioned (12 mm) and stored at 280uC for
immunohistochemistry.
Hair Cell and Supporting Cell Counting
For total hair cell counting, P4 cochleae stained with phallodin
were used because both Fgf20
bGal/+ and Fgf20
bGal/bGal cochleae
were completely differentiated at this stage. For supporting cell
counting, P0 cochleae stained with either phallodin or Prox1 were
used. Because of the incomplete staining pattern of Prox1 from the
base to the apex, we could not count all of the supporting cells.
Instead, we counted more than 300 mm regions of the base,
middle, and apex of the cochlea and normalized counts to
100 mm. Inner and outer hair cells were identified by location and
morphology of phalloidin staining. Inner pillar cells were
distinguished by location and morphology among Prox1+ cells.
Deiters’ cells and outer pillar cells were counted by exclusion of
inner pillar cells from Prox1+ cells. Cell counting was performed
using Image J software.
Organotypic Explant Cochlear Cultures
Embryonic mouse cochlear cultures were established as
described previously [40] with minor modifications. In brief,
cochleae from Fgf20
bGal/+ and Fgf20
bGal/bGal embryos at various
ages (E13.5–E16.5) were dissected, to expose the sensory
epithelium, in ice-cold M199 Hanks solution, transferred to a
Ma-Tek dish (Ma-Tek Corporation), coated with Matrigel (BD
Biosciences), and maintained at 37uC in vitro in experimental
(FGF9 or DAPT) or control culture media for 3–6 d. Recombi-
nant FGF9 and FGF20 protein was obtained from PeproTech Inc.
DAPT was obtained from Sigma. To activate FGF signaling,
FGF9 culture media (1 mg/ml FGF9+1 mM Heparin in
MEM+10% FBS) was added to explant cultures at E13.5,
E14.5, E15.5, or E16.5 for 6, 5, 4, or 3 d, respectively (until age
of E19.5). Control culture media contained (1 mg/ml heparin in
MEM+10% FBS). To inhibit Notch signaling, DAPT (N-[(3,5-
Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethy-
lethyl ester) culture media was added to explant cultures at
E14.5 for 5 d (E19.5). DAPT media: 10 mMD A P T( r e c o n s t i -
tuted in DMSO) in MEM+10% FBS. Control culture media
contained DMSO in MEM+10% FBS. Cochleae were treated
in pairs (i.e., cochlea from left ear received experimental media
while the cochlea from the right ear of the same embryo
received control media). The appropriate culture media was
replaced every 24 h for all explants. Following incubation,
explants were fixed in 4% paraformaldehyde for 30 min and
analyzed by immunohistochemistry.
Immunohistochemistry
Immunohistochemistry was described previously [41]. Briefly,
for whole mount immunofluorescence, cochleae were isolated and
fixed in 4% PFA overnight at 4uC. Samples were washed with PBS
and blocked with PBS containing 0.1% triton X-100 and 0.5%
goat serum. Primary antibody was incubated overnight at 4uC.
Samples were washed with PBS and incubated with a secondary
antibody for 2 h at room temperature. Samples were washed,
placed on a glass microscope slide, coverslipped, and photo-
graphed using a Zeiss LSM 700 confocal microscope. For section
immunofluorescence, frozen sections (12 mm) were washed with
PBS and blocked with 0.1% triton X-100 and 0.5% donkey serum.
Sections were incubated with primary antibodies in a humidified
chamber overnight at 4uC. Sections were then washed and
incubated with secondary antibody for 1 h at room temperature.
Samples were washed, coverslipped with Vectashield Mounting
Media (Vector lab), and photographed using a Zeiss LSM 700
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Systems, 1:40), Myo6 (Proteus Biosciences, 1:500), Myo7a (Proteus
Biosciences, 1:500), Calretinin (Millipore, 1:500), Prox1 (Covance,
1:500), p27 (Neomarkers, 1:500), p75 (Chemicon, 1:500), b-
Galactosidase (Abcam, 1:500), Sox2 (Millipore, 1:500, Santa Cruz
1:200), BrdU (BD Biosciences, 1:500), E-cadherin (Invitrogen,
1:500), and Jag1 (Santa Cruz 1:200).
Statistics
Number of samples is indicated for each experiment. All data
are presented as mean 6 standard deviation (sd). The p value for
difference between samples was calculated using a two-tailed
Student’s t test. p,0.05 was considered as significant.
Supporting Information
Figure S1 Fgf20 gene targeting and morphology of the adult
cochlea. (A) Exon1 of the Fgf20 gene was replaced with a b-
galactosidase gene and a PGK promoter-neomycin gene flanked by
LoxP recombination sites. In vivo Cre mediated recombination (b-
actin
cre) wasused to excise the neomycin cassette.(B)Southern blot of
wild type, Fgf20
bGal/+, and Fgf20
bGal/bGal mouse DNA digested with
BamH1 and probed with a 59 probe that is extrinsic to the targeting
vector.Wild type 15 Kband mutant10 Kbbandsareindicated.(C)
PCR genotyping of the Fgf20
bGal alleles showing wild type (335 bp)
and mutant (498 bp) PCR fragments. Orientation of PCR primers
is indicated. (D) Quantitative RT-PCR of E14.5 inner ear tissue
showing expression of Fgf20 mRNA in wild type tissue, reduced
expression in Fgf20
bGal/+ tissue, and no detectable expression in
Fgf20
bGal/bGal tissue. (E–G) Thin sections stained with toluidine blue
showing comparable cochlear morphology of 2-mo-old wild type
(E), Fgf20
bGal/+ (F), and Fgf20
bGal/bGal(G) mice.
(TIF)
Figure S2 Expression of Fgf20 in the developing inner ear. (A–E)
Whole mount (B, C) and sections (A,D–F) showing bGal
expression in the sensory epithelium of the organ of Corti (A),
utricle (B, D), saccule (C, E), and cristae of the semicircular canals
(F) at P0.
(TIF)
Figure S3 Hair cell and supporting cell formation in the mouse
cochlea. (A,B) Staining of the cochlea with Myo6 expression,
showing fewer differentiated hair cells towards the cochlear apex
in Fgf20
bGal/+ E16.5 embryos (A). In Fgf20
bGal/bGal embryos, no
distinctive phalloidin stained or Myo6 expressing hair cells were
formed in the apical cochlea at E16.5 (B). (C, D) Staining of the P0
cochlea for Myo6 expression showing staining throughout the
length of the cochlea in Fgf20
bGal/+ embryos (C). Fgf20
bGal/bGal
embryos showed decreased Myo6 staining in the cochlear apex
(D). (E, F) Staining of the P7 cochlea for Calretinin expression
showing comparable expression levels in Fgf20
bGal/+ (E) and
Fgf20
bGal/bGal (F) cochleae. (G, H) Staining of the cochlea for Prox1
expression showing two rows of pillar cells and three rows of
Deiters’ cells throughout the cochlea of Fgf20
bGal/+ embryos (G).
Fgf20
bGal/bGal embryos had two rows of pillar cells and two rows of
Deiters’ cells in the base, patches of differentiated supporting cells
containing two rows of pillar cells and three rows of Deiters’ cells
in the middle, and differentiated supporting cells in the apex (H).
(I, J) Staining of the cochlea for p75 expression showing
differentiated pillar cells (strong staining) and Henson’s cells (weak
staining) throughout the length of the cochlea of Fgf20
bGal/+
embryos (I). Pillar cells and Henson’s cells were also identified in
Fgf20
bGal/bGal cochlea, but the pattern matched that of hair cells,
showing patches of differentiated cells and gaps of unlabeled cells
in the middle region of the cochlea. Within the sensory patches,
p75 expressing cells surrounded the outer hair cells (J). (K)
Phalloidin staining of the whole cochlea from P4 embryos,
showing complete differentiation of hair cells in both Fgf20
bGal/+
and Fgf20
bGal/bGal mice.
(TIF)
Figure S4 Normal formation of the cochlear sensory domain in
Fgf20
bGal/bGal embryos. (A, B) Staining of the whole cochlea for
Sox2 expression showing comparable expression patterns in
Fgf20
bGal/+ (A) and Fgf20
bGal/bGal (B) embryos at E13.5. (C, D)
Staining of cochlear sections for Sox2 expression showing
comparable expression patterns in Fgf20
bGal/+ (C) and Fgf20
bGal/bGal
(D) embryos at E14.5. (E, F) Staining of cochlear sections for Jag1
expression showing comparable expression patterns in Fgf20
bGal/+
(E) and Fgf20
bGal/bGal (F) embryos at E14.5. (G, H) BrdU labeling of
E14.5 cochlea showing comparable proliferation in Fgf20
bGal/bGal
(H) and Fgf20
bGal/+ (G) embryos.
(TIF)
Figure S5 Rescue of lateral compartment differentiation by
FGF9. (A–K) Staining for Myo7a expression in Fgf20
bGal/+ and
Fgf20
bGal/bGal cochlear explants treated with or without FGF9.
Treatment of Fgf20
bGal/+ explants with FGF9, either at E13.5 (B)
or E16.5 (F), did not have any effect on hair cell number compared
to untreated explants (A, E). Treatment of Fgf20
bGal/bGal explants
with FGF9 at E13.5 resulted in increased numbers of hair cells and
decreased gaps between hair cell clusters (D) compared to
untreated explants (C). Treatment of Fgf20
bGal/+ or Fgf20
bGal/bGal
explants with FGF9 at E16.5 did not affect hair cell number or the
formation of gaps lacking sensory cells (G, H). (I) Quantitation of
the number of hair cells in explants. The number of outer hair cells
and total hair cells were rescued by treatment with FGF9 at E13.5
but not at E16.5. (J, K) Staining for Myo7a expression and BrdU
incorporation in cochlear explants showing that Myo7a-stained
hair cells do not co-label with BrdU, indicating that cells induced
to differentiate in the gaps between sensory patches (arrow)
differentiate in response to FGF9 without undergoing cell division.
(TIF)
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